The object of this article is to address not so much the technology or management on which life sciences companies depend, but rather the capital that and, in particular, from what sources this capital is available and on what terms and conditions it can be secured. To accomplish this objective,...
Life sciences companies are well positioned to make enormous gains in productivity. They possess a unique excellence in data management and ? from drug discovery to consumer products testing to financial decisions ? they are accustomed to bringing an exacting rigor to their activities. Now they have the opportunity to...
Conformia, the market leader of product andprocess lifecycle management PPLM solutions for life sciences, todayintroduced the Conformia Design Suite, a Web-based software solution thatautomates the design of new drugs during the lab scale environment. TheDesign Suite completes Conformia's Product and Process lifecycle managementoffering for Pharma by providing full capabilities from...
Seasoned CEO to Augment Organization, Drive Value and Partnerships for Clients, Transitioning Assays from the Central Lab to Patient Care Locations without Sacrificing Quality of Test Results SAN JOSE, Calif. -- Alverix, Inc., an optoelectronics company developing portable medical diagnostic instruments in cooperation with leading point-of-care POC diagnostics...
Provista Life Sciences LLC PLS, a diagnosticdevelopment and commercialization company, today announced that ChristaCorn, M.D. has signed on to serve as its resident physician for the BT Test , a bloodtest for the early detection ofbreast cancer . With Dr. Corn in this role, women will now be...
CORNING, N.Y. -- The Board of Directors of Corning Incorporated (NYSE:GLW) today declared a quarterly dividend on the company's common stock of $0.05 per share, payable on September 30, 2008, to holders of record August 29, 2008. About Corning Incorporated Corning Incorporated (www.corning.com) is the world...
Venture Firm Invests at the Convergence of Life Science and Lifestyle SAN FRANCISCO -- Physic Ventures (www.physicventures.com) today announced the closing of Physic Ventures, LP, a $159 million venture capital fund that invests in science-based, consumer-directed health and sustainable living companies. Physic Ventures "invests in keeping people healthy"...
BOSTON, July 15 /PRNewswire/ -- Riverside Partners, a Boston based private equity firm focusing on healthcare and technology businesses, is pleased to announce that The J-Pac and Doyen Medipharm Group ("JPDM" or the "Company"), a leader in contract manufacturing and packaging machinery for the medical device and pharmaceutical industries,...
EAST HILLS, N.Y. -- The Board of Directors of Pall Corporation (NYSE:PLL) today declared a dividend of $0.13 per share payable on August 19, 2008 to shareholders of record as of August 4, 2008. About Pall Corporation Pall Corporation is the global leader in the expanding...
WAYNE, Pa. -- Human Capital and Life Sciences Business Consulting Firm Ashton Tweed, Ltd. today announced that Lisa Goldsborough has joined the firm as Vice President of Client Services. Lisa specializes in developing client relationships with pharmaceutical, biotechnology, medical device and diagnostic companies and will spearhead the company's business development...
- Eva H. Wang Joins Shanghai Office - PALO ALTO, Calif., July 14 /PRNewswire/ -- Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, today announced that Eva H. Wang has joined the firm as a partner....
Council Establishes New Non-Profit Corporation BEVERLY, Mass. -- The North Shore Technology Council NSTC announces the founding and incorporation of the North Shore Life Sciences Accelerator Inc., a new non-profit corporation resulting from the NSTC's mission to foster the region's technology clusters that are key to its economic...
Bio-Rad Laboratories, Inc. (AMEX: BIO) and(AMEX: BIOb), a multinational manufacturer and distributor of life scienceresearch and clinical diagnostic products, will report financial resultsfor the second-quarter 2008 on Tuesday, August 5, 2008, after the close ofthe market. The company will discuss these results in a conference callscheduled for 2 PM Pacific...
DALSA Corporation (TSX: DSA) announced today that the positive results reported in its core business over recent quarters are continuing with particular strength reported within Digital Imaging. With sales of approximately $120 million per year, this division provides high performance cameras, frame grabbers, and image processing for machine vision, industrial...
Appointment of 20-Year Life Science and Drug Discovery Veteran Strengthens Company's Expertise in Discovery and Research Reagents WALTHAM, Mass. -- PerkinElmer, Inc. (NYSE: PKI), a leader in Health Sciences and Photonics, today announced that Alan Fletcher, Ph.D., has joined the Company as vice president, business development for PerkinElmer's...
SAN DIEGO, July 14 /PRNewswire-FirstCall/ -- Vical Incorporated today announced the scheduled presentation of preliminary human safety and immunogenicity data from a Phase 1 trial of the company's VaxfectinR-formulated H5N1 pandemic influenza DNA vaccines on Thursday, July 17, at the IBC Life Sciences Next Generation Vaccines conference (National...
-- Phase 2 Candidate, TRIA-662, Demonstrates Potential to Provide Benefits of Niacin Therapy without Flushing -- -- Clinical-Stage Company Backed by Domain Associates and MVM Life Sciences -- BOSTON & PRINCETON, N.J. -- Domain Associates and MVM Life Science Partners, two leading venture capital firms, today...
TAMPA, Fla. & RESEARCH TRIANGLE PARK, N.C. -- UTEK Corporation (AMEX:UTK) (LSE-AIM:UTK), a leading innovation services company, and Sigma Xi, the international honor society of science and engineering, today announced an alliance which will bring together UTEK's TekScout service and Sigma Xi's membership of approximately 60,000 research scientists and engineers...
OctoPlus N.V. ("OctoPlus" or the "Company") (Euronext: OCTO), thedrug delivery and development company, announces today that it willreceive an additional EUR 2 million under the terms of its bridgefinancing, which was announced on 28 March. The payment is made bythe Company's co-development partner in Locteron®, BiolexTherapeutics, Inc. The additional...
Royal DSM N.V., the global Life Sciences and Materials Sciencescompany headquartered in the Netherlands, today announces theacquisition of the business and substantially all of the assets ofValley Research Inc. of South Bend...
Articles 2008-07-11
<< Previous
page 1 of 1
Next >>
Premier Vendor Content
Whitepapers, webcasts & resources from our Power Center Sponsors
